Navigation Links
Drug addiction can be genetical, says study

The gene that controls the circadian clock of our body may also be responsible// for drug addiction. The gene, also called the Clock gene apart from regulating our sleep and wake patterns also regulates a number of things like hormone levels, blood pressure, heart functions, body temperature, and currently established addiction to drug intake. The gene regulates the inherent vulnerability to drug addiction by rewarding the experience related to drugs which are commonly used for abuse, like cocaine etc. the gene increases the reward response to cocaine through its effect on dopamine pathways. Dopamine is the neurotransmitter connected with the pleasure sensations of the brain. The researchers who had drawn animal parallels had reported that mice deficient in the Clock gene had produced more dopamine when injected with cocaine, much more than the control mice that had the Clock gene. The first group also had more problems with their circadian rhythms when under the influence of cocaine; they were hyperactive with less sleep and exhibited a distinct preference for the location where the drug was administered. The research suggesting the link between lack of sleep and tendency to abuse drugs may open new ways to research for the deeper understanding of human drug addiction. Reference: Proceedings of the National Academy of Sciences, online edition, June 2005
'"/>




Page: 1

Related medicine news :

1. Pen-nibbling addiction
2. Teen brain changes increase cigarette addiction
3. New treatment possible for drug addiction
4. A herbal drug addiction releiver
5. De-addiction Drug Works For Alcoholics Too
6. Drug addiction higher in rural Punjab: study
7. Food addiction similar to Drug addiction!!
8. NHS De-addiction, Rehabilitation waiting time ticking into months
9. Babies born to drug addicted mothers, treated for drug addictions
10. A new study surpasses Gene Therapy Hurdle
11. A question on study of Adult Stem Cell
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... ... 2017 , ... The Centers for Advanced Orthopaedics (The Centers), ... Robinson as chief operating officer (COO). In this role, Robinson brings more than ... of simplifying business processes and developing growth strategies to increase market share. ...
(Date:6/26/2017)... RU (PRWEB) , ... June 26, 2017 , ... ... released a whitepaper that pledges to solve many catastrophic issues within funding campaigns. ... 2017. , The typical notion of crowdfunding - the raising of funds through the ...
(Date:6/25/2017)... ... 25, 2017 , ... An increase in wetter weather in the Northern California ... with that; a humdinger of an allergy season. A relief from drought conditions is ... misery-causing grass and weed pollen. , “Our patients have been reporting the typical ...
(Date:6/24/2017)... PA (PRWEB) , ... June 24, 2017 , ... ... held in Erie, PA at the Sheraton Erie Bayfront and Erie Convention Center ... evidence based medicine experience, exhibits, a student quiz bowl, award and scholarship presentations, ...
(Date:6/23/2017)... Alexandria, VA (PRWEB) , ... June 23, 2017 ... ... short of what is needed and will ultimately do significant harm to people ... care to everyone. , "While it leaves in place the Affordable Care ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... DUBLIN , June 7, 2017 Endo ... on June 7, 2017, the Hon. Joseph R. ... District of West Virginia , entered ... Systems, Inc. Pelvic Repair System Products Liability Litigation (the ... filed MDL cases to provide expert disclosures on specific ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
Breaking Medicine Technology: